The worst part I would imagine for holders is the succinct brief and direct statement that the drug has failed to differentiate itself after all this nonsense.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.